Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT00252941 | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 20 | The Cleveland ClinicOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT00264420 | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation | completed | Phase 1 | 4 | The Cleveland ClinicOTHER | 0 | Dec 21, 2010 | clinicaltrials |
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00668083 | Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer(Sorse) | completed | — | 214 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT00692874 | Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy(AZTEK EXT) | completed | — | 1,646 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
| NCT01250483 | Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | completed | — | 174 | Seoul National University HospitalOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00106392 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | completed | Phase 4 | 131 | Astellas Pharma IncINDUSTRY | 1 | Nov 23, 2010 | clinicaltrials |
| NCT00002881 | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00816452 | Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer(InoPro) | completed | — | 180 | SanofiINDUSTRY | 1 | Nov 3, 2010 | clinicaltrials |
| NCT00005947 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 127 | DendreonINDUSTRY | 1 | Nov 1, 2010 | clinicaltrials |
| NCT00541788 | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation | completed | Phase 1 | 10 | University Hospital, GhentOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT00598312 | Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer | completed | Phase 3 | 201 | Oakwood Laboratories, LLCINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT00065442 | Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | completed | Phase 3 | 512 | DendreonINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00201916 | Shorter Radiation Schedule for the Treatment of Prostate Cancer | completed | Phase 3 | 936 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 17, 2010 | clinicaltrials |
| NCT00004014 | Liposomal Doxorubicin in Treating Patients With Prostate Cancer | completed | Phase 2 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01168323 | Spaced Education to Optimize Prostate Cancer Screening | completed | N/A | 95 | Harvard University Faculty of MedicineOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00982800 | Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? | completed | Phase 4 | 60 | Sunnybrook Health Sciences CentreOTHER | 1 | Aug 6, 2010 | clinicaltrials |
| NCT00430235 | A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer | completed | Phase 2 | 39 | British Columbia Cancer AgencyOTHER | 1 | Aug 5, 2010 | clinicaltrials |
| NCT00193193 | Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Aug 4, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00193232 | Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00242060 | Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy | completed | N/A | — | University Health Network, TorontoOTHER | 1 | Jul 15, 2010 | clinicaltrials |
| NCT01025479 | Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent | completed | — | 829 | AstraZenecaINDUSTRY | 1 | Jun 30, 2010 | clinicaltrials |
| NCT00269555 | Effects of GCP on Prostate Cancer. | completed | N/A | 62 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00305929 | Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | completed | Phase 2 | 8 | STEBA FranceINDUSTRY | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00181558 | Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone | completed | Phase 2 | 44 | Massachusetts General HospitalOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00871585 | Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide | completed | — | 340 | AstraZenecaINDUSTRY | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00908674 | Androcur Effects on Quality of Life | completed | — | 245 | BayerINDUSTRY | 1 | Apr 13, 2010 | clinicaltrials |
| NCT00557037 | A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer | completed | Phase 2 | 60 | MEI Pharma, Inc.INDUSTRY | 1 | Apr 8, 2010 | clinicaltrials |
| NCT00003307 | Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | completed | Phase 2 | 25 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00048841 | Prevention of Osteoporosis in Men With Prostate Cancer | completed | Phase 3 | 112 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00415779 | ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer(ZANTE) | completed | Phase 1 | 36 | National Cancer Institute, NaplesOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00084526 | Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00523484 | Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts(CHAMPION) | completed | — | 1,200 | AstraZenecaINDUSTRY | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00811876 | Retrospective, Non-interventional Study of Depo-Eligard®.(OCT) | completed | — | 140 | Astellas Pharma IncINDUSTRY | 1 | Jan 22, 2010 | clinicaltrials |
| NCT00196807 | Prostate Cancer Screening: Fostering Informed Decisions | completed | Phase 3 | 543 | Georgetown UniversityOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00196781 | Treatment Decision Making in Early-Stage Prostate Cancer | completed | Phase 3 | 168 | Georgetown UniversityOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00134706 | A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | completed | Phase 2 / Phase 3 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00140478 | Mifepristone (RU-486) in Androgen Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00165386 | MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients | completed | N/A | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00035997 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00087659 | A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy | completed | N/A | — | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00166725 | Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients | completed | Phase 2 | 40 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00139191 | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | completed | N/A | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00139204 | Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients | completed | N/A | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00541281 | Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer | completed | Phase 2 | 150 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | Oct 27, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 24, 2010source: clinicaltrials